Latest stories
Featured
Hikma expands its agreement with AFT Pharmaceuticals for the commercialisation of injectable pain medication Combogesic®...
Press Release, Business Development
12 February 2024
- Hikma announces settlement agreement for Xyrem® (sodium oxybate) U.S. class action lawsuits Press Release, Corporate 08 May 2025 Hikma announces settlement agreement for Xyrem® (sodium oxybate) U.S. class action lawsuits
- S&P upgrades Hikma Pharmaceuticals PLC and its Senior Notes to ‘BBB’ on continued good business momentum; outlook stable Press Release, Corporate 08 May 2025 S&P upgrades Hikma Pharmaceuticals PLC and its Senior Notes to ‘BBB’ on continued good business momentum; outlook stable
- Hikma reiterates full year guidance following good start to the year Press Release, Corporate 24 April 2025 Hikma reiterates full year guidance following good start to the year
- Inspiring women of Hikma - Meet Nesrine Nouhi, General Manager of Hikma France Insight, Life at Hikma 17 April 2025 Inspiring women of Hikma - Meet Nesrine Nouhi, General Manager of Hikma France
Related content